Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferons in neurology].

F Aguilar Rebolledo1

  • 1Unidad de Investigación en Epidemiología Clínica y Neurología CMN, Siglo XXI, IMSS. fran.aguilar-neurol@lycos.com

Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|March 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[SPECT-99mTc-HMPAO in a case of epilepsia partialis continua and focal encephalitis].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1996
Same author

[Comments on the article, Alzheimer's disease].

Gaceta medica de Mexico·1995
Same author

[Acute transverse myelitis and multiple sclerosis. Study and treatment of 10 patients].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1986
Same author

[Multiple sclerosis: clinical, paraclinical study and management of 24 cases].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1985
Same author

[Treatment of acute demyelinating inflammatory polyradiculoneuritis with megadoses of methylprednisolone. Prospective study].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1985
Same journal

Respiratory health and quality of life in chronic cannabis users: An exploratory study.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
Same journal

The meaning of "p-value": Pursuing clinical and statistical significance. A narrative review.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
Same journal

The risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in patients with psoriasis: An updated systematic review and meta-analysis.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
Same journal

Evaluation of the potential impact of the peri-operative transfusion trigger score algorithm on the optimization of blood components: A comparative study in a trauma hospital.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
Same journal

Pernicious anemia predominates among Mexican adults with vitamin B12 deficiency: clinical and laboratory findings from a tertiary referral center.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
Same journal

Association between early blood pressure variability and short-term outcomes in patients with hypertension and acute stroke: A prospective cohort study.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
See all related articles

Interferon (INF) therapy, particularly INF beta, shows promise in managing relapsing-remitting multiple sclerosis (MS RR). It helps reduce complications and may slow disease progression.

Area of Science:

  • Immunology
  • Neurology
  • Oncology

Context:

  • Interferons (IFNs) are cytokines crucial for antiviral immunity.
  • IFNs modulate immune responses and inhibit cell division, impacting cancer and autoimmune diseases.
  • Neurological applications of IFNs, especially in multiple sclerosis, are under recent investigation.

Purpose:

  • To review the biological activity, clinical uses, side effects, and indications of interferons (IFNs) in neurological diseases.
  • To specifically focus on the role of INF beta in managing multiple sclerosis (MS).
  • To discuss the evaluation of clinical status using the Expanded Disability Status Scale (EDSS).

Summary:

  • Recombinant INF beta-1a and glucosylated INF beta-1 have demonstrated positive outcomes in patients with active relapsing-remitting multiple sclerosis (MS RR).

Related Experiment Videos

  • Treatment with INF beta in MS RR patients is associated with decreased incidence and complications, and potential halting of disease progression.
  • The manuscript covers the broad biological actions of IFNs and their specific utility in neurological conditions, emphasizing INF beta's established clinical role.

    • Impact:

    • INF beta represents a significant therapeutic option for multiple sclerosis, offering a way to manage disease activity and potentially improve patient outcomes.
    • Understanding IFN's immunomodulatory effects provides insights into treating various neurological disorders.
    • The review provides a comprehensive resource for clinicians and researchers on INF therapy in multiple sclerosis.